All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @xoashh.s2 on TikTok · 110s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @xoashh.s2's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00If you're new to peptides, NAD may not be the one that you want to start with first.
  2. 0:06She's spicy.
  3. 0:07I can mitigate the spiciness with clove, but for some reason, NAD, I know they say it has
  4. 0:12to do with the pH balance and all of that no matter what I do, she's been sitting out for
  5. 0:17I don't know, 40 minutes and I bet she's still going to burn.
  6. 0:21So just a heads up.
  7. 0:23NAD burns quite a bit.
  8. 0:29She just burns.
  9. 0:30She's not going to explain it and you have to go really, really slow.
  10. 0:32Sometimes I'll pull out and move somewhere else because...
  11. 0:35But this has always been my best spot.
  12. 0:39And if you're new to peptides, you might not be able to handle that.
  13. 0:47I'm just being so honest.
  14. 0:49My friend ordered and she got redder.
  15. 0:51She also got...
  16. 0:54NAD and I was like, start with the redder.
  17. 0:57Let your first injection be.
  18. 0:59Maybe I need to talk to JT and you can tell me what I'm doing wrong.
  19. 1:02Or maybe I need to buy different backwater.
  20. 1:06NAD just burns.
  21. 1:07I commented it was like you didn't take all of that and I'll be so honest, I did it.
  22. 1:21People say you feel a rush, but I think those are the people who do it too fast.
  23. 1:26I think you should take your time.
  24. 1:28Like I'm very slow with injecting NAD.
  25. 1:44I lied.
  26. 1:45Take NAD.
  27. 1:46Who cares if it stinks?
  28. 1:47I just have the best workout and it changed my whole mood.

@xoashh.s2's peptide therapy claims need context

xoashh.s2

TikTok creator

17.9K viewsWatch on TikTok

Quick answer

The creator is self-administering compounded NAD+ via subcutaneous injection and reporting significant injection site burning, which is consistent with documented discomfort from rapid or concentrated NAD+ administration. She attributes acute workout performance and mood improvements to the injection, though subcutaneous NAD+ lacks the pharmacokinetic data to support reliable predictions of these effects from a single dose. Bacteriostatic water selection and compound concentration are both legitimate variables affecting tolerability, and this administration is outside any standardized or FDA-approved clinical protocol.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @xoashh.s2's peptide therapy claims need context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@xoashh.s2's peptide therapy claims need context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@xoashh.s2's peptide therapy claims need context" from xoashh.s2. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is self-administering compounded NAD+ via subcutaneous injection and reporting significant injection site burning, which is consistent with documented discomfort from rapid or concentrated NAD+ administration.

The reason this review is not generic is the source wording and the canonical claim label "peptides tiktok 7618788585910570270." In this clip, the useful excerpt is: "If you're new to peptides, NAD may not be the one that you want to start with first." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against NAD+ metabolism and its roles in cellular processes during ageing (2021), Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women (2021), and Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults (2018), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Subcutaneous NAD+ administration lacks robust pharmacokinetic studies.
People who land here are usually trying to understand whether the Peptide social video fact-checks claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is self-administering compounded NAD+ via subcutaneous injection and reporting significant injection site burning, which is consistent with documented discomfort from rapid or concentrated NAD+ administration.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is self-administering compounded NAD+ via subcutaneous injection and reporting significant injection site burning, which is consistent with documented discomfort from rapid or concentrated NAD+ administration. She attributes acute workout performance and mood improvements to the injection, though subcutaneous NAD+ lacks the pharmacokinetic data to support reliable predictions of these effects from a single dose. Bacteriostatic water selection and compound concentration are both legitimate variables affecting tolerability, and this administration is outside any standardized or FDA-approved clinical protocol.
  • NAD+ injection site burning is clinically documented and linked to administration rate and concentration, not pH alone. Slowing injection is the evidence-backed mitigation strategy.
  • Subcutaneous NAD+ administration lacks robust pharmacokinetic studies. Most clinical NAD+ research uses IV delivery, making absorption and dosing predictions for subcutaneous routes speculative.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • NAD+ injection site burning is clinically documented and linked to administration rate and concentration, not pH alone. Slowing injection is the evidence-backed mitigation strategy.
  • Subcutaneous NAD+ administration lacks robust pharmacokinetic studies. Most clinical NAD+ research uses IV delivery, making absorption and dosing predictions for subcutaneous routes speculative.
  • A 2021 Science study (Yoshino et al.) found NMN improved muscle insulin sensitivity over 10 weeks in postmenopausal women. Single-dose acute workout effects are not established in the literature.
  • Compounded NAD+ products are not FDA-approved and vary in purity and concentration across compounding pharmacies. Product quality directly affects both efficacy and tolerability.
  • The 'clove for burn mitigation' claim has no peer-reviewed support in the context of peptide or NAD+ injections. Eugenol has topical dental anesthetic data only.
  • Anyone self-injecting compounded peptides outside medical supervision is operating without a safety net for adverse reactions, contamination risks, or incorrect reconstitution.
  • Mood and performance improvements reported after a single NAD+ injection cannot be separated from placebo effect, adrenaline response to injection, or confirmation bias without controlled conditions.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @xoashh.s2 actually say?

The creator documented a subcutaneous NAD+ injection on TikTok, warning viewers that it burns intensely and that newcomers should start with a different peptide first. She described injecting slowly, mentioned trying clove to reduce the sting, and said a friend had a similar reaction. Her bottom line: "NAD just burns" and the payoff was "the best workout" and a mood shift afterward.

To her credit, she was not making medical claims or citing a protocol. This was experiential, personal, and framed as a caution to beginners. She also pushed back on the idea of rushing the injection, which is actually reasonable advice. But there are a few things worth unpacking, including whether what she is injecting qualifies as NAD+, why it burns, and whether the workout and mood effects are plausible or just placebo.

Does the science back this up?

The burning sensation is real and well-documented. It is not fully explained by pH alone, though that is a contributing factor. Studies do support NAD+ administration affecting energy metabolism and mood-adjacent pathways.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in cellular energy production and sirtuins signaling. IV NAD+ administration has been studied more rigorously than subcutaneous injection. Birkmayer et al. (1996, Acta Neurologica Scandinavica Supplementum) and later work by Conze et al. (2019, Scientific Reports) on NAD+ precursors like NMN and NR demonstrated that systemic NAD+ levels can be raised through supplementation, with effects on energy metabolism. The burning during IV infusion is well-reported in clinical settings and linked to the rate of administration and concentration, not just pH. Slowing the injection, as the creator recommends, is consistent with clinical practice for reducing discomfort. However, subcutaneous NAD+ injection is not a standardized medical protocol, and absorption data for this route is limited compared to IV.

What did they get wrong (or right)?

She got the burn warning right. She got the slow-injection advice right. Where things get shakier is the attribution of a specific workout boost and mood lift to NAD+ specifically.

Crediting NAD+ for "the best workout" after a single subcutaneous dose is plausible in theory but very difficult to verify. NAD+ precursors have shown performance-adjacent effects in longer supplementation studies. Yoshino et al. (2021, Science) found that NMN supplementation improved muscle insulin sensitivity in postmenopausal women over 10 weeks. A single injection is a different scenario entirely. The acute mood shift she describes is harder to attribute. Adrenaline from the injection experience itself, confirmation bias, or the simple act of doing something intentional for your health can produce a temporary mood lift. The creator does not claim NAD+ cures anything, which keeps her out of the most dangerous misinformation territory. But presenting anecdotal workout and mood effects as a reliable outcome is misleading without that context.

Her mention of "backwater" likely refers to bacteriostatic water used for reconstitution. Using the wrong diluent does affect pH and discomfort, so that detail matters more than she gave it credit for.

What should you actually know?

NAD+ injections are not FDA-approved for the uses described here. Compounded NAD+ products vary significantly in purity and concentration, and subcutaneous administration lacks robust clinical evidence compared to IV delivery.

The burning sensation is real and has been documented in IV contexts at rates above clinical tolerance thresholds. If you are experiencing significant burning during a subcutaneous injection, that is a signal worth taking seriously, not just pushing through. The quality of the bacteriostatic water and the concentration of the compound both affect tolerability. Anyone considering NAD+ therapy should do so under medical supervision, with a licensed prescriber who can assess whether it is appropriate, source compounded products from an FDA-registered pharmacy, and monitor response. The creator's personal experience is not a protocol. Her results, positive or otherwise, cannot be generalized. And the "clove" mentioned as a burn-mitigation strategy has no clinical evidence behind it in this context.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

xoashh.s2 · TikTok creator

17.9K views on this video

@xoashh.s2's peptide therapy claims need context

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about nad+ injection site burning?

NAD+ injection site burning is clinically documented and linked to administration rate and concentration, not pH alone. Slowing injection is the evidence-backed mitigation strategy.

What does the video say about subcutaneous nad+ administration lacks robust pharmacokinetic studies. most clinical nad+?

Subcutaneous NAD+ administration lacks robust pharmacokinetic studies. Most clinical NAD+ research uses IV delivery, making absorption and dosing predictions for subcutaneous routes speculative.

What does the video say about a 2021 science study (yoshino et al.) found nmn improved?

A 2021 Science study (Yoshino et al.) found NMN improved muscle insulin sensitivity over 10 weeks in postmenopausal women. Single-dose acute workout effects are not established in the literature.

What does the video say about compounded nad+ products?

Compounded NAD+ products are not FDA-approved and vary in purity and concentration across compounding pharmacies. Product quality directly affects both efficacy and tolerability.

What does the video say about the 'clove for burn mitigation' claim has no peer-reviewed support?

The 'clove for burn mitigation' claim has no peer-reviewed support in the context of peptide or NAD+ injections. Eugenol has topical dental anesthetic data only.

What does the video say about anyone self-injecting compounded peptides outside medical supervision?

Anyone self-injecting compounded peptides outside medical supervision is operating without a safety net for adverse reactions, contamination risks, or incorrect reconstitution.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by xoashh.s2, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.